Skip to main content

Arhaus Reports First Quarter 2026 Financial Results

BOSTON HEIGHTS, Ohio, May 07, 2026 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted products and heirloom-quality design, reported first quarter results for the period ended March 31, 2026. First Quarter 2026 HighlightsCompared to the first quarter of 2025:Net revenue increased 0.9% to $314 million Gross margin decreased 1.0% to $114 million Selling, general and administrative expenses increased 1.9% to $112 million Net and comprehensive income decreased 54.5% to $2 million Adjusted EBITDA decreased 3.1% to $18 million Comparable Delivered Sales(1) decreased 1.7% Comparable Written Sales(2) decreased 5.7%John Reed, Co-Founder and Chief Executive Officer, said:“We achieved the highest first-quarter net revenue in Arhaus...

Continue reading

Enovis Announces First Quarter 2026 Results

First-quarter sales growth of 5% on a reported basis First-quarter Reconstructive sales grew 11% on a reported basis Reiterating full-year 2026 revenue, adjusted EBITDA, adjusted EPS, and Free Cash Flow Conversion guidanceDallas, TX, May 07, 2026 (GLOBE NEWSWIRE) — Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter ended April 3, 2026. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET. First Quarter 2026 Financial Results Enovis’ first-quarter net sales of $589 million grew 5% on a reported basis and 3% on an organic basis from the same quarter in 2025. First quarter results reflect continued execution in P&R and Recon, stable end...

Continue reading

VGP to launch capital increase of approximately €250 million via an accelerated bookbuild offering

PRESS RELEASE Regulated InformationInside Information   Announcement in application of article 7:97, §4/1 BCCA NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OF  AMERICA, JAPAN, CANADA, SOUTH AFRICA OR AUSTRALIA 7 May 2026, 12:00 pm, Antwerp, Belgium: VGP NV (‘VGP’ or the ‘Company’), a European provider of high-quality logistics and semi-industrial real estate, announces the following:VGP is launching a capital increase in cash by means of a private placement of new shares via an accelerated bookbuild offering to international institutional investors (the ‘Capital Increase’ or the ‘Transaction’). VGP is seeking to raise gross proceeds in the Capital Increase of approximately € 250 million. The accelerated bookbuild offering will start immediately after publication of this press release. The reference shareholder of the Company,...

Continue reading

Marquette National Corporation Reports First Quarter 2026 Results

CHICAGO, May 07, 2026 (GLOBE NEWSWIRE) — Marquette National Corporation (OTCQX: MNAT) today reported net loss of $2.86 million for the quarter ended March 31, 2026, compared to net loss of $2.95 million for the first three months of 2025.  The loss per share for the first three months of 2026 was $(0.65), as compared to a loss of $(0.67) per share for the comparable period in 2025. At March 31, 2026, total assets were $2.190 billion, a decrease of $35.1 million, compared to $2.225 billion at December 31, 2025. Total loans decreased by $26.8 million, to $1.386 billion compared to $1.412 billion at the end of 2025. Total deposits decreased by $4.0 million to $1.770 billion compared to $1.774 billion at the end of 2025. Paul M. McCarthy, Chairman & CEO, said, “the net loss for the current quarter was due primarily to the unrealized...

Continue reading

The continuing business realised revenue of DKK 263.3 million compared to DKK 261.5 million in the same period last year. Operating profit (EBIT) was DKK 22.7 million comapred to DKK 20.9 million in the same period last year.

Summary (comparative figures in parenthesis):In the first half of the year, Gabriel Holding A/S’ continuing operations realised growth of DKK 1.8 million, corresponding to 1%, brining revenue to DKK 263.3 million (DKK 261.5 million).In the first half of the year, revenue growth was realised in both the European and North American businesses, while a slight decline was realised in Asia. Management assesses that market conditions in Europe and Asia were negatively affected in Q2 of the year, while the US market showed a continued slight upward trend. During the first two quarters of the year, efforts in sales, marketing and product development have increased through hiring and investment in tools, as the economy of the continuing business has allowed it.The operating profit (EBIT) for the continuing business was DKK 22.7 million...

Continue reading

Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial

ZUG, Switzerland, May 07, 2026 (GLOBE NEWSWIRE) —Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME designations in ON underscore the significant unmet need and therapeutic potential of Privosegtor as a neuroprotective candidateOculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, today announced that it has received written agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) regarding PIONEER-1, the first registrational trial within the PIONEER Program evaluating Privosegtor...

Continue reading

GEN Korean BBQ Launches Costco Roadshow Series, Marking Next Phase of Retail Expansion

GEN Restaurant Group brings its proven in-store demo model and restaurant-trained workforce to Costco warehouse locations across the country this summer CERRITOS, Calif., May 07, 2026 (GLOBE NEWSWIRE) — GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), operator of GEN Korean BBQ, the largest full-service Korean BBQ restaurant chain in the United States, today announced the launch of a Costco roadshow demonstration series. Over the course of two months, GEN will bring its signature marinated, ready-to-cook meats directly to Costco members through in-store sampling events at several regions nationwide. This launch represents the next chapter in GEN’s growing retail presence, and a significant step toward permanent placement in Costco’s freezer aisles.  GEN’s selection for a Costco roadshow...

Continue reading

Himax Technologies, Inc. Declares Cash Dividend for FY2025

25.2 cents per ADS payable on July 10, 2026 TAINAN, Taiwan, May 07, 2026 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today declared a cash dividend of 25.2 cents per ADS, equivalent to 12.6 cents per ordinary share, for the year of 2025. The cash dividend will be payable on July 10, 2026 to all the shareholders of record as of June 30, 2026. The ADS book will be closed for issuance and cancellation from June 23, 2026 to June 30, 2026. Typically, Himax pays out its yearly dividend at approximately the middle of its current calendar year based on the Company’s previous year financial performance. “Since our IPO in 2006, we have consistently rewarded shareholders for their ongoing commitment...

Continue reading

Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial

Special Protocol Assessment (SPA) agreement with the U.S. FDA provides regulatory alignment on the registrational path for Privosegtor in optic neuritis (ON) FDA Breakthrough Therapy and EMA PRIME designations in ON underscore the significant unmet need and therapeutic potential of Privosegtor as a neuroprotective candidateZUG, Switzerland, May 7 2026 — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, today announced that it has received written agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) regarding PIONEER-1, the first registrational trial within the PIONEER Program evaluating Privosegtor for the treatment of...

Continue reading

TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry

Establishes domestic platform in advanced graphite, addressing a multi-billion-dollar end market underpinned by U.S. supply-chain reshoring and next-generation nuclear deployment TOMI Environmental Solutions, Inc. and Carbonium Core, Inc. to Present at Wall Street Reporter’s Next Super Stocks Livestream May 7, 2026, at 1:00pm ET FREDERICK, Md., May 07, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (Nasdaq: TOMZ) (“TOMI” or the “Company”) today is providing clarification regarding its previously announced non-binding letter of intent (the “LOI”) for a merger transaction to acquire 100% of the outstanding equity of Carbonium Core, Inc. (“Carbonium Core”), a U.S.-based developer of nuclear-grade graphite for advanced reactor technologies (the “Proposed Transaction”). Transaction Summary: TOMI provide all-stock consideration...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.